Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Taina Turpeenniemi Hujanen"'
Autor:
Aino Rajamaki, Marc Sorigue, Roosa E.I. Prusila, Milla E.L. Kuusisto, Hanne Kuitunen, Esa Jantunen, Santiago Mercadal, Taina Turpeenniemi-Hujanen, Juan-Manuel Sancho, Kaisa Sunela, Outi Kuittinen
Publikováno v:
Acta Oncologica, Vol 63, Iss 1 (2024)
Background: The modern-day therapeutic landscape for follicular lymphoma (FL) includes a number of highly effective therapies. Patients and methods: We set out to determine progression-free survival (PFS) after front line, second line, and third lin
Externí odkaz:
https://doaj.org/article/ce557e7d205e449bb320adff8cfc7f23
Autor:
Elina Kaprio, Roosa Prusila, Susanna Tokola, Milla E. L. Kuusisto, Esa Jantunen, Hanne Kuitunen, Taina Turpeenniemi‐Hujanen, Outi Kuittinen
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background Rituximab‐based combinations are the standard of care in diffuse large B‐cell lymphoma (DLBCL) and follicular lymphoma (FL). Despite being on market for over 20 years, some of the adverse effects associated with the use of rit
Externí odkaz:
https://doaj.org/article/3ac1de65e388439496cfaa35d413d9a7
Autor:
Inka Puhakka, Hanne Kuitunen, Pekka Jäkälä, Eila Sonkajärvi, Taina Turpeenniemi-Hujanen, Aino Rönkä, Tuomas Selander, Miika Korhonen, Outi Kuittinen
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background We report here the first population-based incidence rates and prognosis of primary central nervous system lymphoma (PCNSL) in Finland. Methods Finnish Cancer Registry data by histological diagnosis and tumor location (2007–2017)
Externí odkaz:
https://doaj.org/article/68958d7c3f1c415c9dc223ce5da3953c
Publikováno v:
Cancer Medicine, Vol 10, Iss 9, Pp 3035-3044 (2021)
Abstract The application of positron emission tomography (PET)‐computed tomography (CT) in treatment response evaluation has increased in diffuse large B‐cell lymphoma (DLBCL), although its predictive value is controversial. We retrospectively an
Externí odkaz:
https://doaj.org/article/9f499e464cc74ae881308f6558d90092
Publikováno v:
Cancer Medicine, Vol 9, Iss 6, Pp 1966-1977 (2020)
Abstract Bulky and residual tumor are considered to increase the risk of relapse in diffuse large B‐cell lymphoma (DLBCL) patients. Radiotherapy is conventionally used to reduce the risk, but the evidence is controversial. We performed a retrospect
Externí odkaz:
https://doaj.org/article/0dbe05d6e37447d7aad0216040e2becd
Autor:
Heikki Joensuu, Päivi Heikkilä, Jorma Isola, Taina Turpeenniemi-Hujanen, Mikael Lundin, Vesa Kataja, Liisa Sailas, Kaija Holli, Ralf Bützow, Maarit Sarlomo-Rikala, Tiina Lehtimäki, Johan Lundin, Harri Sihto
Supplementary Data from Molecular Subtypes of Breast Cancers Detected in Mammography Screening and Outside of Screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b7190cb1d5357bfbf5f3e761ff1303d
https://doi.org/10.1158/1078-0432.22439419.v1
https://doi.org/10.1158/1078-0432.22439419.v1
Autor:
Heikki Joensuu, Päivi Heikkilä, Jorma Isola, Taina Turpeenniemi-Hujanen, Mikael Lundin, Vesa Kataja, Liisa Sailas, Kaija Holli, Ralf Bützow, Maarit Sarlomo-Rikala, Tiina Lehtimäki, Johan Lundin, Harri Sihto
Purpose: The frequency and significance of gene expression profile-derived molecular subtypes of breast cancers found in mammography screening are unknown.Experimental Design: We identified breast cancers diagnosed in women of any age living in defin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b87d6f52c7c8056d629aa8e5f2c2d23
https://doi.org/10.1158/1078-0432.c.6516889.v1
https://doi.org/10.1158/1078-0432.c.6516889.v1
Autor:
Vesa Kiviniemi, Vesa Korhonen, Jukka Kortelainen, Seppo Rytky, Tuija Keinänen, Timo Tuovinen, Matti Isokangas, Eila Sonkajärvi, Topi Siniluoto, Juha Nikkinen, Seppo Alahuhta, Osmo Tervonen, Taina Turpeenniemi-Hujanen, Teemu Myllylä, Outi Kuittinen, Juha Voipio
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0174072 (2017)
Chemotherapy aided by opening of the blood-brain barrier with intra-arterial infusion of hyperosmolar mannitol improves the outcome in primary central nervous system lymphoma. Proper opening of the blood-brain barrier is crucial for the treatment, ye
Externí odkaz:
https://doaj.org/article/a1e9cb295d744ed0928be133e0418330
Autor:
Hanne Kuitunen, Janette Kemppainen, Outi Kuittinen, Pyry H Kotkaranta, Milla E.L. Kuusisto, Risto Pirinen, Riina K Ollikainen, Taina Turpeenniemi-Hujanen, Hanna-Riikka Teppo
Publikováno v:
Leukemia & Lymphoma. 62:2151-2160
Although treatment for diffuse large B-cell lymphoma (DLBCL) has taken some notable steps in the 2000s, there are still subgroups of patients suffering from high mortality and relapse rates. To further improve treatment outcomes, it is essential to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20a79f56319896e391a840c506fd1e9f
https://doi.org/10.1080/10428194.2021.1913150
https://doi.org/10.1080/10428194.2021.1913150
Autor:
Esa Jantunen, Elina Kaprio, Milla E.L. Kuusisto, Ville Makkonen, Hanne Kuitunen, Outi Kuittinen, Saila Kauppila, Kirsi-Maria Haapasaari, Taina Turpeenniemi-Hujanen, Peeter Karihtala
Publikováno v:
Annals of Hematology
Although overall survival in diffuse large B cell lymphomas (DLBCL) has improved, central nervous system (CNS) relapse is still a fatal complication of DLBCL. For this reason, CNS prophylaxis is recommended for patients at high risk of CNS disease. H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2484721d81a87c1460e225e163d57c4e
https://doi.org/10.1007/s00277-020-04140-0
https://doi.org/10.1007/s00277-020-04140-0